Analytical Data
-
Gene name
FAM110B
- Application
-
Alternative Names
FAM110B; C8orf72Protein FAM110B
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TC76
-
Expression Region
1-370aa
-
Molecular Weight
44.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM110B, a member of the FAM110 gene family, has garnered attention in recent years due to its potential role in various biological processes and diseases. The FAM110 family is known to be involved in cellular functions such as proliferation, differentiation, and apoptosis, with FAM110B specifically noted for its implications in cancer biology. Research indicates that FAM110B may be involved in the regulation of gene expression and the modulation of signaling pathways, particularly those linked to tumorigenesis. Its expression patterns in different tissues and tumor types suggest that FAM110B could serve as a biomarker for cancer diagnosis or prognosis. Furthermore, studies have shown that alterations in FAM110B expression may contribute to the aggressiveness of certain cancers, making it a potential target for therapeutic interventions. The exploration of FAM110B as a recombinant protein allows researchers to delve deeper into its functional roles, investigate its interactions with other cellular components, and assess its impact on cellular behavior. Understanding the molecular mechanisms underlying FAM110B's activity may unveil new insights into cancer biology and open avenues for innovative treatment strategies. As such, the study of FAM110B recombinant protein is pivotal in elucidating its biological significance and therapeutic potential in cancer and other diseases.
